The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Variations in compliance among hypertensive patients by drug class: implications for health care costs
Open accessAbstract
Health care decision-makers require more information on differences in compliance rates associated with alternative classes of antihypertensive drugs and the implications of these differences for health care utilization and costs. We examined medical claims data from the Pennsylvania Medicaid Management Information System to investigate compliance rates for four major antihypertensive drug classes (angiotensin-converting enzyme [ACE] inhibitors, beta-blockers, calcium antagonists, and diuretics) and the health care costs associated with noncompliance. Multivariate analysis was used to relate antihypertensive drug class with compliance and variations in compliance with health care costs. The highest estimated rates of compliance were associated with ACE inhibitors and calcium antagonists, and these rates were significantly greater than with beta-blockers and diuretics. Moreover, poor compliance was associated with higher health care costs. Efforts to increase compliance with antihypertensive drug therapy are needed to improve patient outcomes and reduce health care costs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rizzo et al64 reported cost findings through subgroup analysis of five conditions. For all conditions, the total healthcare costs were higher for non-adherent groups compared with adherent.”
From Economic impact of medication non-adherence by disease groups: a systematic review (2018) · cites this paper as [64]
Citations
Cites
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
International Classification of Diseases
Jones, F. A. (1978) · Gut · doi:10.1136/gut.19.12.1175 · Cited by 2,911
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,608
How often is medication taken as prescribed? A novel assessment technique
Cramer, J. A. (1989) · JAMA · doi:10.1001/jama.261.22.3273 · Cited by 1,021
The Effect of Prescribed Daily Dose Frequency on Patient Medication Compliance
Eisen, S. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.9.1881 · Cited by 817
Overview of patient compliance with medication dosing: a literature review.
Greenberg, R. N. (1984) · PubMed · Cited by 419
The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population
McCombs, J. S., Nichol, M. B., Newman, C. M., & Sclar, D. A. (1994) · Medical Care · doi:10.1097/00005650-199403000-00003 · Cited by 187
Pullar, T., Birtwell, A. J., Wiles, P. G., Hay, A., & Feely, M. P. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.191 · Cited by 168
Clark, L. T. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90443-l · Cited by 143
How often is medication taken as prescribed?
de Wit, R., van Dam, F. S. A. M., Buuren, A. V., & van der Heijden, C. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)92083-5 · Cited by 127
Cited by
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
The challenge of patient adherence.
Martin, L. R., Williams, S. L., Haskard, K. B., & DiMatteo, M. R. (2005) · PubMed Central · Cited by 1,024
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
“Unadjusted costs were measured in six studies with the annual total healthcare costs and/or total costs of non-adherence ranging from $1433 to $8377.(64) 66 80 92 94 95 Rizzo et al(64) reported cost findings through subgroup analysis of five conditions.”
BackgroundNew medication adherence scale versus pharmacy fill rates in seniors with hypertension.
Krousel-Wood, M. A., Islam, T., Webber, L. S., Ré, R. N., Morisky, D. E., & Muntner, P. (2009) · PubMed · Cited by 683
Estimating medication persistency using administrative claims data.
Sikka, R., Xia, F., & Aubert, R. E. (2005) · PubMed · Cited by 456
Metadata
- Authors
- Rizzo, J. A., & Robert Simons, W.
- Affiliations
- Yale University (US)
- ORCID
- Rizzo, John A.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 19
- Issue
- 6
- Pages
- 1446-1457
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2026070904
- Cited by
- 174
- References
- 24
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 10 · 2013: 5 · 2012: 9
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1439 d)
- Locations
- Clinical Therapeutics (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication adherence, antihypertensive drugs, hypertension, health care costs, ACE inhibitors, beta-blockers, calcium channel blockers, diuretics, Medicaid claims data
- MeSH terms
- Analysis of Variance, Antihypertensive Agents, Female, Humans, Hypertension, Male, Middle Aged, Patient Compliance, Pennsylvania, Retrospective Studies, Cost Savings, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variations in compliance among hypertensive patients by drug class: implications for health care costs. https://app.cochat.ai/papers/10.1016/s0149-2918(97)80018-5
- The paper
- Rizzo, J. A., & Robert Simons, W. (1997). Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(97)80018-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.